Last update 16 May 2025

SELA-070

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
SELA 070, SELA070
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Other Diseases
Active Indication
Tobacco Use Disorder
Inactive Indication
Smoking Cessation
Originator Organization
Selecta Biosciences, Inc.Selecta Biosciences, Inc.
Active Organization
National Institutes of HealthNational Institutes of HealthSelecta Biosciences, Inc.Selecta Biosciences, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SELA-070
NCT03148925
/ CompletedPhase 1
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Pharmacodynamics of Increasing Subcutaneous Doses of SELA-070 in Healthy Adult Smokers
100 Clinical Results associated with SELA-070
Login to view more data
100 Translational Medicine associated with SELA-070
Login to view more data
100 Patents (Medical) associated with SELA-070
Login to view more data
100 Deals associated with SELA-070
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Smoking CessationPhase 1
Belgium
Selecta Biosciences, Inc.Selecta Biosciences, Inc.
11 May 2017
Tobacco Use DisorderPhase 1-
Selecta Biosciences, Inc.Selecta Biosciences, Inc.
-
Tobacco Use DisorderPhase 1-
National Institutes of HealthNational Institutes of Health
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free